Becton Dickinson reported $23.3B of revenue over the trailing twelve months, +17% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $23.3B (to Q3 2026). Net income: $941M, trailing twelve months to Q3 2026. Operating margin: 10.0%, trailing twelve months to Q3 2026. EPS: $3.32, trailing twelve months to Q3 2026.

BDXBecton Dickinson

Healthcare

$183.72+26% 1Y

$183.72

$136.0952 weeks$192.00

BDX as reported

Becton Dickinson reported $23.3B of revenue over the trailing twelve months, +17% on the year before. 11 reported series are charted on this page, each one as filed.

$23.3B

Revenue, trailing twelve months · to Q3 2026 · +17% against the twelve months before

Net income: $941M
Net income · −41% year on year · trailing twelve months to Q3 2026
Operating margin: 10.0%
Operating margin · trailing twelve months to Q3 2026
EPS: $3.32
EPS · −39% year on year · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for BDX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$23.3B	+17%	Q3 2026
Net income	$941M	−41%	Q3 2026
EPS	$3.32	−39%	Q3 2026
Gross margin	47%	n/a	Q3 2026
Operating margin	10.0%	n/a	Q3 2026
Net margin	3.5%	n/a	Q3 2026
ROE	5.5%	n/a	Q3 2026
ROA	2.6%	n/a	Q3 2026
ROIC	5.0%	n/a	Q3 2026
Free cash flow	$2.97B	n/a	Q1 2025 · 6 quarters behind
P/E	55.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.